Ocular Surface: What Matters in 2024?
Interview with Justin Schweitzer, OD, from Vance Thompson Vision. Dr. Schweitzer reduces the pressure on how to efficiently manage glaucoma patients with ocular surface dryness. He gives up the rundown on topical eyedrops, preservatives, and surgical options to balance pressure and dryness.
Thea Pharma, Inc. is an independent pharmaceutical company specializing in the commercialization of eye care products.
Established in 2019, Thea Pharma is the United States subsidiary of Laboratoires Théa, a global leader and pioneer in ophthalmics. We are committed to serve doctors that treat the anterior segment and ocular surface conditions.
Our goal is to deliver uncompromising care that allows all stakeholders to envision the future of ophthalmic treatment with eyes wide open.
WE CAN BUILD A FUTURE FILLED WITH BETTER OUTCOMES. TOGETHER.
Ocular Surface: What Matters in 2024?
Interview with Justin Schweitzer, OD, from Vance Thompson Vision. Dr. Schweitzer reduces the pressure on how to efficiently manage glaucoma patients with ocular surface dryness. He gives up the rundown on topical eyedrops, preservatives, and surgical options to balance pressure and dryness.
